Working… Menu

A Multi-Dose Study With a Treatment for Open-Angle Glaucoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00705770
Recruitment Status : Withdrawn (Change in study design)
First Posted : June 26, 2008
Last Update Posted : May 30, 2012
Information provided by (Responsible Party):
Alcon Research

Brief Summary:
The purpose of this study is to determine whether Anecortave Acetate is effective for lowering intraocular pressure caused by open-angle glaucoma.

Condition or disease Intervention/treatment Phase
Open-Angle Glaucoma Drug: Anecortave Acetate Drug: Placebo Phase 2 Phase 3

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Study Start Date : May 2008
Actual Primary Completion Date : July 2008
Actual Study Completion Date : July 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Glaucoma

Arm Intervention/treatment
Placebo Comparator: 1
Placebo treatment with vehicle
Drug: Placebo
Placebo treatment with vehicle

Experimental: 2
Low dose of study medication
Drug: Anecortave Acetate

Low dose

Sustained release depot suspension

Experimental: 3
Middle dose of study medication
Drug: Anecortave Acetate

Middle dose

Sustained release depot suspension

Experimental: 4
High dose of study medication
Drug: Anecortave Acetate

High dose

Sustained release depot suspension

Primary Outcome Measures :
  1. Mean Intraocular Pressure [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. Percent of patients with therapeutic benefit, number and percent of treatment failure and time to treatment failure [ Time Frame: 6 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients at least 18 years old with a clinical diagnosis of Open-Angle Glaucoma for at least 6 months and currently treated with a monotherapy hypotensive medication

Exclusion Criteria:

  • Prior angle surgery in the study eye, severe visual field loss in either eye, and any other form of glaucoma besides open-angle glaucoma

Layout table for additonal information
Responsible Party: Alcon Research Identifier: NCT00705770     History of Changes
Other Study ID Numbers: C-07-58
First Posted: June 26, 2008    Key Record Dates
Last Update Posted: May 30, 2012
Last Verified: July 2008
Keywords provided by Alcon Research:
Open-Angle Glaucoma
Intraocular Pressure
Anecortave Acetate
Additional relevant MeSH terms:
Layout table for MeSH terms
Glaucoma, Open-Angle
Ocular Hypertension
Eye Diseases
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Growth Substances
Physiological Effects of Drugs
Growth Inhibitors
Antineoplastic Agents